Neisseria gonorrhoeae: Properties, Pathogenesis, Virulence Factors, and Lab Diagnosis

A 23-year-old man presents with a 3-day history of purulent urethral discharge and dysuria. A urethral swab is taken and a Gram stain is performed. The result showed: Gram-negative diplococci, predominantly intracellular within polymorphonuclear leucocytes. No culture is needed for presumptive diagnosis. This Gram stain appearance in urethral discharge from a symptomatic male is diagnostic for gonorrhea.

The clinician is about to prescribe ceftriaxone but stops to check current treatment guidelines (the CDC combination therapy recommendations have changed since 2020 due to rising azithromycin resistance). The correct current regimen is ceftriaxone alone. Azithromycin is no longer added routinely.

This case illustrates why Neisseria gonorrhoeae demands attention in clinical microbiology: a rapidly evolving resistance profile, simple Gram stain diagnosis in men, complex multi-site disease in women, and a global burden of over 82 million new infections annually.

Neisseria is the only pathogenic gram-negative coccus (precisely diplococcus). Two species of Neisseria cause disease in humans; Neisseria meningitidis and Neisseria gonorrhoeae.

Humans are only known hosts of N. gonorrhoeae. Neisseria gonorrhoeae (often called gonococcus) causes gonorrhea, the second most common sexually transmitted disease (STDs) of worldwide importance (Chlamydial infections are more common). It causes disease only in humans.

Neisser described the causative agent of gonorrhea, N. gonorrhoeae, in 1879.

Morphology

Neisseria gonorrhoeae is Gram-negative: a Gram-negative diplococcus. In detail:

1. Gram-negative cocci, usually seen in pairs (diplococci) with the adjacent sides flattened (typically kidney-shaped); it looks like two coffee beans facing each other.
2. In urethral discharge, it is predominately found within the polymorphs.
3. Sensitive to dehydration and cold conditions.
4. Gonococci do not contain capsules (meningococci do).

Mode of transmission

1. Neonates acquire Neisseria gonorrhoeae from the mother during passage through the birth canal. In newborn infants, Neisseria gonorrhoeae causes ophthalmia neonatorum (purulent conjunctivitis).
2. Sexual transmission: Acquired during unprotected sex with infected partner. Gonorrhea is one of the most common bacterial sexually transmitted infections; for the full list of STIs and how gonococcal urethritis is distinguished from nongonococcal causes, see the list of sexually transmitted infections and their causative agents.

Virulence Factors of Neisseria gonorrhoeae

N. gonorrhoeae has evolved a sophisticated repertoire of virulence factors that allow it to adhere to mucosal surfaces, evade immune defences, acquire nutrients, and resist killing. These factors explain how a fastidious organism with no environmental reservoir successfully establishes infection in the harsh environment of the urogenital tract.

Figure: Virulence factors of Neisseria gonorrhoeae

1. Pili (Fimbriae): The Principal Virulence Factor

Pili are the most important virulence determinant of N. gonorrhoeae. They mediate:

• Initial attachment to non-ciliated columnar epithelial cells of the urethra, endocervix, pharynx, and conjunctiva
• Antiphagocytic action: piliated gonococci resist killing by neutrophils; non-piliated strains are avirulent in human experimental infection

Pili are composed of pilin proteins that undergo both antigenic variation (expression of antigenically different pilin proteins from a pool of silent gene cassettes) and phase variation (on/off switching of pili expression). This variation:

• Allows the organism to evade antibody-mediated immunity
• Makes vaccine development against pili extremely difficult
• Is the reason why repeated gonococcal infections do not confer lasting immunity

2. Outer Membrane Proteins: PorB (Porin)

PorB is the major outer membrane porin protein of N. gonorrhoeae. It is a voltage-gated ion channel with multiple virulence functions:

• Mediates epithelial cell invasion under low-phosphate conditions
• Serum resistance: interacts with regulators of both classical and alternative complement pathways, contributing to resistance to complement-mediated killing
• Modulates innate immune response: affects reactive oxygen species generation by neutrophils

N. gonorrhoeae expresses PorB in one of two allelic forms: P.IA strains are associated with disseminated gonococcal infection (DGI); P.IB strains typically cause localised urogenital infections.

3. Opacity (Opa) Proteins

Opa proteins are a family of antigenically distinct outer membrane proteins that undergo phase-variable expression: each gonococcal strain carries 11–12 opa genes but expresses a variable subset:

• Promote persistence in the female genital tract
• Mediate invasion of epithelial cells
• Responsible for the opaque colony morphology on agar (Opa-expressing colonies appear opaque; non-expressing colonies appear transparent)
• Phase variation in Opa expression allows immune evasion throughout the course of infection

4. IgA1 Protease

N. gonorrhoeae produces two distinct extracellular IgA1 proteases that cleave the heavy chain of secretory IgA1 at the hinge region:

• Destroys secretory IgA at mucosal surfaces, the antibody that would otherwise block attachment
• Split products of IgA1 have been found in genital secretions of women with gonorrhea
• Production of IgA protease is shared with N. meningitidis, reflects their common mucosal niche

Figure: Role of IgA protease (Image source: Tufts University)

5. Lipooligosaccharide (LOS)

Unlike most Gram-negative bacteria, N. gonorrhoeae produces lipooligosaccharide (LOS) rather than full-length lipopolysaccharide: it has lipid A and core oligosaccharides but no repeating O-antigen side chains:

• Activates the alternative complement pathway
• Marked endotoxic activity, stimulates TNF-α production causing local tissue damage
• LOS undergoes molecular mimicry: its lacto-N-neotetraose structure mimics human cell surface oligosaccharides, reducing antibody recognition
• Sialylation of LOS (acquisition of host sialic acid) further enhances serum resistance

6. Transferrin-Binding Proteins (TbpA and TbpB)

Iron is essential for gonococcal growth and is limiting in host tissues. N. gonorrhoeae scavenges iron exclusively from human transferrin and lactoferrin using two transferrin-binding proteins:

• TbpA and TbpB specifically bind human transferrin (not transferrin from other species)
• This iron acquisition mechanism is essential for infection and represents a potential vaccine target

Virulence Factor Summary

Disease caused by Neisseria gonorrhoeae

Gonococci cause localized infections, usually in the genital tract, and disseminated infections.

Figure: Ophthalmia neonatorum

1. Gonorrhea in men is characterized primarily by urethritis accompanied by dysuria and a purulent discharge. Epididymitis can occur.
2. In women, infection is located primarily in the endocervix, causing a purulent vaginal discharge and intermenstrual bleeding (cervicitis). The most frequent complication in women is an ascending infection of the uterine tubes (salpingitis, pelvic inflammatory disease (PID)), which can result in sterility or ectopic pregnancy as a result of scarring of tissues.
3. In newly born children: Ophthalmia neonatorum, a purulent conjunctivitis that develops within the first days of life, can involve the cornea and cause blindness if untreated.

Disseminated gonococcal infections occurs via the blood stream. Gonococcal strains causing disseminated infections are usually resistant to serum and complement. Disseminated infections commonly manifest as septic arthritis, tenosynovitis, pustules in the skin, endocarditis, and meningitis.

Laboratory diagnosis of Gonorrhoea

Figure: Algorithm for culture and identification of Neisseria gonorrhoeae

Sample

urethral/cervical/vaginal discharge

• To obtain a urethral specimen swab (cotton or rayon swab) is inserted approximately 2cm in urethra and rotated gently before withdrawing.
• If there is profuse urethral discharge in male, it can be collected without inserting the swab.
• A few drops of first voided urine can be used in males, but the sensitivity is low compared to discharge.

Transport

Swabs collected for isolation of gonococci may be transported to the laboratory in modified Stuart's or Amies charcoal transport media and held at room temperature until inoculated to culture media. Good recovery of gonococci is possible if swabs are cultured within 12 hours of collection.

Gram Staining

Figure: Neisseria gonorrhoeae on modified New York City (NYC) medium

For men, a gram-stained smear of urethral discharge (exudate) showing intracellular Gram-negative diplococci is diagnostic. But as women may carry normal vaginal flora such as Veillonella or occasional gram-negative coccobacilli , may resemble gonococci, same results in case of women may not be diagnostic so culture and identification process is needed, which is a confirmatory test.

Culture

Modified Thayer Martin Medium is most often used.  Modified New York City Medium (MNYC) is also used for the culture of Neisseria gonorrhoeae. MNYC also supports the growth of Mycoplasma.

Biochemical tests for Neisseria gonorrhoeae identification

1. Oxidase Test: Positive
2. Ferments glucose but not maltose, sucrose or lactose
3. DNase Test: Negative
4. Beta-galactosidase (ONPG) Test: Negative
5. Glutamyl-aminopeptidase (GAP) Test: Negative

Serology

Serological tests to determine the presence of antibody to gonococci are not useful for diagnosis.

Molecular Diagnosis

Presence of gonococcal nucleic acids in patient specimens, using amplification or non-amplification method. These tests are highly sensitive and specific.

Figure: Historical image Dissemination of the Message "Penicillin cures Gonorrhea"

Treatment and Antimicrobial Resistance

Antimicrobial resistance in Neisseria gonorrhoeae is categorized by the CDC as an urgent threat, and the treatment has changed repeatedly as the organism defeated one drug after another.

Current recommendation:

• Uncomplicated urogenital or anorectal gonorrhea: ceftriaxone is the drug of choice.
• If chlamydial coinfection cannot be excluded: add doxycycline (avoided in pregnancy and in young children).
• Azithromycin is no longer added routinely: rising azithromycin resistance made dual therapy counterproductive, adding resistance pressure without clinical benefit.

Specific doses and routes are clinical decisions set by current guidelines and are not covered here; what matters for understanding the organism is why the regimen keeps changing, which the timeline below shows.

1. 1935: Antimicrobial treatment of gonorrhea started in 1935 after discovery of sulfanilamide. Neisseria gonorrhoeae developed widespread resistance to sulfanilamide within the first ten years resulting in treatment failures.
2. 1940: Penicillin is used as a treatment of choice for gonorrhea. Penicillin remained effective for next few decades despite a continuous and insidious increase in MICs.
3. 1976: End of era of penicillin with discovery and worldwide spread of Neisseria gonorrhoeae harboring plasmid-mediated beta-lactamases.
4. 2010: Alarming decrease in cefixime susceptibility reported from around the world.
5. 2018: Combination of azithromycin and ceftriaxone – has failed to treat the disease
6. 2020–2023: CDC removes azithromycin from routine dual therapy due to azithromycin resistance exceeding 5% in surveillance data. Ceftriaxone monotherapy is now the standard. WHO classifies N. gonorrhoeae as a priority 2 (high) pathogen for development of new antibiotics. Oral cefixime is no longer recommended due to pharmacodynamic concerns.

The clinical importance of this change: Providers who continue using the pre-2020 regimen (ceftriaxone + azithromycin) are prescribing suboptimal therapy that contributes to azithromycin resistance without providing additional clinical benefit. Always verify current guidelines as N. gonorrhoeae resistance evolves rapidly.

Key exam facts

How to Remember

The Gram stain diagnosis rule (one line): intracellular Gram-negative diplococci are diagnostic from a symptomatic male urethra, but only presumptive from a female genital sample, because vaginal flora can mimic gonococci. The reason is in the Gram Staining section above; the shortcut is: men, diagnostic; women, confirm with culture or NAAT.

The maltose test distinguishes gonococcus from meningococcus: Gonococcus: glucose only (no maltose) Meningococcus: glucose AND maltose. Memory: Gonococcus = Glucose only; Meningococcus = Maltose too

For a full systematic comparison of both organisms (properties, diseases, virulence, and lab tests side by side) see the dedicated article: Differences between N. gonorrhoeae and N. meningitidis

Virulence factor logic, why each one matters:

1. Pili → get in (attachment); phase variation → evade antibody
2. Opa proteins → stay in (persistence); phase variation → evade again
3. IgA protease → destroy the IgA trying to block attachment
4. PorB → resist complement killing in blood (disseminated disease)
5. LOS → damage tissue (TNF-α); mimic host to avoid detection
6. Transferrin binding → steal iron to survive in host tissues

The disseminated gonorrhea triad: Skin pustules + septic arthritis + tenosynovitis = disseminated gonococcal infection (DGI) Organisms causing DGI typically express P.IA PorB and are serum-resistant (complement-resistant)

Where students get confused

Gram stain is diagnostic in men but not in women. This is not about sensitivity, it is about the background flora: a woman's genital tract carries organisms (such as Veillonella) that resemble gonococci on Gram stain, so a positive smear there is only presumptive and needs culture or NAAT. In a symptomatic man's urethral discharge there is no such look-alike flora, so the smear is diagnostic.

Gonococcus ferments glucose only; meningococcus adds maltose. Both are oxidase-positive Gram-negative diplococci, so the sugars separate them. Gonococcus = Glucose only; Meningococcus = Maltose too.

Gonococcus has no capsule; meningococcus does. This is a frequent mix-up because they are otherwise so alike. The capsule is a meningococcal feature, and it is part of why meningococcus disseminates and gonococcus usually stays local.

No lasting immunity, so reinfection is common. Students expect an infection to produce protective immunity. Gonococcal pili and Opa proteins undergo antigenic and phase variation, so the antibodies made against one infection do not recognize the next. This is also why a pili vaccine has failed.

LOS, not LPS. N. gonorrhoeae makes lipooligosaccharide (no repeating O-antigen), not the full lipopolysaccharide of most Gram-negatives. Calling it LPS misses a testable point and the molecular-mimicry mechanism that depends on the LOS structure.

References

1. Tille, P. M. (2022). Bailey and Scott's Diagnostic Microbiology (15th ed.). Elsevier.
2. Edwards, J. L., & Apicella, M. A. (2004). The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clinical Microbiology Reviews, 17(4), 965–981. https://doi.org/10.1128/CMR.17.4.965-981.2004
3. Quillin, S. J., & Seifert, H. S. (2018). Neisseria gonorrhoeae host adaptation and pathogenesis. Nature Reviews Microbiology, 16(4), 226–240. https://doi.org/10.1038/nrmicro.2017.169
4. Centers for Disease Control and Prevention. (2021). Sexually Transmitted Infections Treatment Guidelines, 2021: Gonococcal Infections. MMWR, 70(4). https://www.cdc.gov/std/treatment-guidelines/gonorrhea.htm
5. World Health Organization. (2016). WHO Guidelines for the Treatment of Neisseria gonorrhoeae. Geneva: WHO.